{"id":"https://openalex.org/W4255855348","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps3125","title":"A phase 2 study of Ad.p53 DC vaccine in combination with indoximod in metastatic solid tumors.","display_name":"A phase 2 study of Ad.p53 DC vaccine in combination with indoximod in metastatic solid tumors.","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W4255855348","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps3125"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.tps3125","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps3125","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps3125","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090789911","display_name":"Hatem Hussein Soliman","orcid":"https://orcid.org/0000-0001-6644-2264","observed_orcids":["https://orcid.org/0000-0001-6644-2264"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hatem Hussein Soliman","raw_affiliation_strings":["H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111541235","display_name":"Susan E. Minton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Susan E. Minton","raw_affiliation_strings":["H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015970851","display_name":"Roohi R. Ismail-Khan","orcid":"https://orcid.org/0000-0002-1301-6736","observed_orcids":["https://orcid.org/0000-0002-1301-6736"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roohi Ismail-Khan","raw_affiliation_strings":["H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059240684","display_name":"Hyo Sook Han","orcid":"https://orcid.org/0000-0002-0072-0257","observed_orcids":["https://orcid.org/0000-0002-0072-0257"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hyo S. Han","raw_affiliation_strings":["H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051154663","display_name":"William E. Janssen","orcid":"https://orcid.org/0000-0001-5066-9608","observed_orcids":["https://orcid.org/0000-0001-5066-9608"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Janssen","raw_affiliation_strings":["Moffitt Cancer Center, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Moffitt Cancer Center, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070688456","display_name":"Nicholas N. Vahanian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127016","display_name":"NewLink Genetics (United States)","ror":"https://ror.org/03spep839","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas N. Vahanian","raw_affiliation_strings":["NewLink Genetics, Ames, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewLink Genetics, Ames, IA","institution_ids":["https://openalex.org/I4210127016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112243123","display_name":"Charles J. Link","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127016","display_name":"NewLink Genetics (United States)","ror":"https://ror.org/03spep839","country_code":"US","type":"company","lineage":["https://openalex.org/I4210127016"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles J. Link","raw_affiliation_strings":["NewLink Genetics, Ames, IA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NewLink Genetics, Ames, IA","institution_ids":["https://openalex.org/I4210127016"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090809833","display_name":"HOWARD Z. STREICHER","orcid":"https://orcid.org/0000-0003-3683-9804","observed_orcids":["https://orcid.org/0000-0003-3683-9804"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard Streicher","raw_affiliation_strings":["Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102841436","display_name":"Daniel M. Sullivan","orcid":"https://orcid.org/0009-0003-0951-9781","observed_orcids":["https://orcid.org/0009-0003-0951-9781","https://orcid.org/0000-0002-2183-1773"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Sullivan","raw_affiliation_strings":["H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5046273815","display_name":"Scott Joseph Antonia","orcid":"https://orcid.org/0000-0002-6686-3824","observed_orcids":["https://orcid.org/0000-0002-6686-3824"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Joseph Antonia","raw_affiliation_strings":["H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center &amp; Research Institute, Tampa, FL","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"TPS3125","last_page":"TPS3125"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.006399999838322401,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12996","display_name":"Cancer Research and Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1305","display_name":"Biotechnology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/indoximod","display_name":"indoximod","score":0.9900000095367432},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.8629999756813049},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.6549999713897705},{"id":"https://openalex.org/keywords/dendritic-cell-vaccine","display_name":"dendritic cell vaccine","score":0.5379999876022339},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7269999980926514},{"id":"https://openalex.org/keywords/tryptophan-metabolism","display_name":"tryptophan metabolism","score":0.7120000123977661},{"id":"https://openalex.org/keywords/simon-s-two-stage-design","display_name":"Simon two-stage design","score":0.6359999775886536},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8475062847137451},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.42491576075553894},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4188350439071655},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.415246844291687}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.tps3125","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps3125","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps3125","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2601304651","https://openalex.org/W2212833192","https://openalex.org/W2783488707","https://openalex.org/W2598118864","https://openalex.org/W2395215198","https://openalex.org/W2094454810","https://openalex.org/W3013416722","https://openalex.org/W4298869405","https://openalex.org/W2502903836","https://openalex.org/W2521566919"],"abstract_inverted_index":{"TPS3125":[0],"Background:":[1],"Indeolamine":[2],"2,3":[3],"dioxygenase":[4],"(IDO)":[5],"is":[6,33,58,121,210,230,274],"an":[7,34,59],"inducible":[8],"tryptophan-catabolizing":[9],"enzyme":[10],"that":[11,42],"downregulates":[12],"the":[13,49,107,122,220,233,268,277,284],"immune":[14],"system.":[15],"Many":[16],"tumor":[17,174],"cell":[18,54],"types":[19],"overexpress":[20],"IDO":[21,35,45],"to":[22,52,73,83,94,197,244,267],"avoid":[23],"elimination":[24],"by":[25],"infiltrating":[26],"cytotoxic":[27],"T":[28],"cells.":[29],"Indoximod":[30],"(1-methyl-D-tryptophan/":[31],"D1MT)":[32],"pathway":[36],"inhibitor.":[37],"Published":[38],"preclinical":[39],"data":[40],"suggests":[41],"blockade":[43],"of":[44,125,163,186,190,201,208,223,236,248,253,258,262,271,283],"with":[46,156,195,213,241,250,281],"indoximod":[47,126,191],"enhances":[48],"immunologic":[50,140],"response":[51,81,93,123,215,239],"dendritic":[53],"(DC)":[55],"vaccines.":[56],"Ad.p53":[57,70],"adenovirus":[60],"used":[61],"for":[62,91,217],"generating":[63],"DC":[64],"vaccines":[65],"directed":[66],"against":[67],"p53":[68,169],"epitopes.":[69],"when":[71],"given":[72,192],"previously":[74],"treated":[75,105],"SCLC":[76],"patients":[77,102,212,285],"significantly":[78],"increased":[79],"their":[80],"rate":[82,124],"subsequent":[84,95],"chemotherapy.":[85],"Data":[86],"showing":[87],"a":[88,148,237,251,256],"similar":[89],"trend":[90],"enhanced":[92],"chemotherapy":[96,165],"was":[97],"presented":[98],"in":[99,106,118,128,166,172],"breast":[100,130,159],"cancer":[101,131],"who":[103],"were":[104],"phase":[108,119],"I":[109],"trial":[110,273,291],"using":[111],"Ad.p53DC":[112,202],"and":[113,139,276],"indoximod.":[114],"The":[115,227],"primary":[116],"endpoint":[117],"II":[120],"+Ad.p53":[127],"metastatic":[129,158,167],"patients.":[132,226],"Secondary":[133],"endpoints":[134],"include":[135],"safety,":[136],"PFS,":[137],"OS,":[138],"correlates.":[141],"Methods:":[142],"This":[143],"Phase":[144],"2":[145],"study":[146,228,278,288],"uses":[147],"single":[149],"arm,":[150],"Simon":[151],"two":[152],"stage":[153,207,222,270],"design.":[154],"Patients":[155],"measurable,":[157],"cancer,":[160],"<3":[161],"lines":[162],"prior":[164],"setting,":[168],"immunohistochemistry":[170],">5%":[171],"archival":[173],"specimen,":[175],"ECOG":[176],"0-2,":[177],"no":[178],"autoimmune":[179],"disease":[180],"are":[181,264],"eligible.":[182],"Study":[183],"treatment":[184],"consists":[185],"1600mg":[187],"PO":[188],"BID":[189],"continuously":[193],"along":[194],"up":[196],"6":[198],"fixed":[199],"doses":[200],"SQ":[203],"vaccinations":[204],"q2weeks.":[205],"First":[206],"accrual":[209],"12":[211],"one":[214],"required":[216],"progression":[218],"into":[219],"second":[221],"25":[224],"additional":[225],"design":[229],"based":[231],"on":[232],"alternative":[234],"hypothesis":[235],"20%":[238],"rate,":[240],"90%":[242],"power":[243],"detect":[245],"this":[246,272],"level":[247],"activity":[249],"significance":[252],".09":[254],"(assuming":[255],"total":[257],"4":[259],"responses":[260],"out":[261],"37":[263],"observed).":[265],"Accrual":[266],"first":[269],"completed":[275],"remains":[279],"open":[280],"some":[282],"still":[286],"undergoing":[287],"treatment.":[289],"Clinical":[290],"information:":[292],"NCT01042535.":[293]},"counts_by_year":[{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2022-05-12T00:00:00"}